Windlas Biotech Limited
Windlas Biotech Limited (WINDLAS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
windlas.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 Cr | 153 Cr | 162 Cr | 171 Cr | 175 Cr | 187 Cr | 195 Cr | 203 Cr | 210 Cr | 222 Cr | 233 Cr | 238 Cr |
| Operating expenses (approx.) | 128 Cr | 134 Cr | 142 Cr | 149 Cr | 154 Cr | 164 Cr | 170 Cr | 177 Cr | 184 Cr | 194 Cr | 209 Cr | 213 Cr |
| EBITDA | 17 Cr | 19 Cr | 20 Cr | 22 Cr | 21 Cr | 23 Cr | 25 Cr | 26 Cr | 27 Cr | 29 Cr | 24 Cr | 25 Cr |
| OPM % | 11.8% | 12.2% | 12.5% | 12.8% | 11.9% | 12.3% | 12.6% | 12.6% | 12.6% | 12.8% | 10.5% | 10.6% |
| Other income | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 5 Cr | 4 Cr | 5 Cr | 5 Cr | 4 Cr | 5 Cr | 4 Cr |
| Interest | 0.24 Cr | 0.28 Cr | 0.30 Cr | 0.28 Cr | 0.49 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 6 Cr | 7 Cr | 7 Cr | 8 Cr | 7 Cr | 8 Cr | 8 Cr | 8 Cr |
| Profit before tax | 16 Cr | 18 Cr | 20 Cr | 23 Cr | 18 Cr | 20 Cr | 20 Cr | 21 Cr | 23 Cr | 24 Cr | 20 Cr | 20 Cr |
| Tax % | 26.2% | 23.4% | 23.8% | 24.9% | 26.4% | 22.8% | 23.4% | 21.8% | 24.0% | 24.5% | 24.9% | 20.7% |
| Net profit | 12 Cr | 14 Cr | 15 Cr | 17 Cr | 13 Cr | 16 Cr | 16 Cr | 16 Cr | 18 Cr | 18 Cr | 15 Cr | 16 Cr |
| EPS (₹) | ₹5.79 | ₹6.75 | ₹7.26 | ₹8.17 | ₹6.47 | ₹7.49 | ₹7.45 | ₹7.77 | ₹8.43 | ₹8.48 | ₹7.12 | ₹7.58 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 466 Cr | 513 Cr | 631 Cr | 760 Cr | 904 Cr | Sign in for TTM |
| Operating expenses (approx.) | 414 Cr | 453 Cr | 553 Cr | 666 Cr | 799 Cr | Sign in for TTM |
| EBITDA | 52 Cr | 60 Cr | 78 Cr | 94 Cr | 105 Cr | Sign in for TTM |
| OPM % | 11.3% | 11.7% | 12.4% | 12.4% | 11.6% | Sign in for TTM |
| Other income | 7 Cr | 10 Cr | 13 Cr | 18 Cr | 18 Cr | Sign in for TTM |
| Interest | 1 Cr | 0.79 Cr | 1 Cr | 4 Cr | 5 Cr | Sign in for TTM |
| Depreciation | 12 Cr | 12 Cr | 13 Cr | 28 Cr | 31 Cr | Sign in for TTM |
| Profit before tax | 46 Cr | 57 Cr | 77 Cr | 80 Cr | 87 Cr | Sign in for TTM |
| Tax % | 16.4% | 25.3% | 24.5% | 23.5% | 23.6% | Sign in for TTM |
| Net profit | 38 Cr | 43 Cr | 58 Cr | 61 Cr | 66 Cr | Sign in for TTM |
| EPS (₹) | ₹18.80 | ₹19.70 | ₹27.97 | ₹29.19 | ₹31.60 | Sign in for TTM |
| Dividend payout % | 0.0% | 17.9% | 14.3% | 18.8% | 18.3% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 11 Cr | 10 Cr | 10 Cr | 10 Cr | 11 Cr |
| Reserves | 384 Cr | 392 Cr | 440 Cr | 495 Cr | 570 Cr |
| Borrowings | 6 Cr | 0.44 Cr | 0.11 Cr | 27 Cr | 30 Cr |
| Other liabilities | 90 Cr | 126 Cr | 176 Cr | 228 Cr | 297 Cr |
| Total liabilities | 491 Cr | 529 Cr | 626 Cr | 760 Cr | 907 Cr |
| Fixed assets (net) | 91 Cr | 103 Cr | 169 Cr | 195 Cr | 187 Cr |
| CWIP | 8 Cr | 14 Cr | 6 Cr | 3 Cr | 56 Cr |
| Investments | 65 Cr | 107 Cr | 173 Cr | 223 Cr | 268 Cr |
| Inventories | 59 Cr | 75 Cr | 62 Cr | 81 Cr | 62 Cr |
| Trade receivables | 111 Cr | 117 Cr | 136 Cr | 167 Cr | 227 Cr |
| Cash & bank | 0.57 Cr | 4 Cr | 5 Cr | 0.42 Cr | 0.54 Cr |
| Other assets | 158 Cr | 111 Cr | 74 Cr | 90 Cr | 106 Cr |
| Total assets | 491 Cr | 529 Cr | 626 Cr | 760 Cr | 907 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 9 Cr | 61 Cr | 109 Cr | 68 Cr | 105 Cr |
| Cash from investing | -155 Cr | -14 Cr | -92 Cr | -74 Cr | -92 Cr |
| Cash from financing | 130 Cr | -44 Cr | -15 Cr | 1 Cr | -13 Cr |
| Net cash flow | -15 Cr | 3 Cr | 2 Cr | -5 Cr | 0.11 Cr |
| Free cash flow (OCF − Capex) | -6 Cr | -10 Cr | 71 Cr | 16 Cr | 37 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 11.9% | 14.4% | 17.4% | 15.8% | 15.0% |
| ROE % | 9.6% | 10.6% | 0.0% | 0.0% | 11.4% |
| Debtor days | 87 | 83 | 79 | 80 | 92 |
| Inventory days | 69 | 53 | 7666 | 12725 | 1807 |
| Days payable | 75 | 62 | 16211 | 26149 | 6969 |
| Cash conversion cycle | 81 | 74 | -8466 | -13344 | -5071 |
| Debt / equity | 0.02 | 0.0011 | 0.0002 | 0.05 | 0.05 |
| Current ratio | 4.06 | 2.92 | 2.51 | 2.11 | 1.95 |
| Net debt / EBITDA | 0.00 | -0.05 | -0.07 | 0.28 | 0.28 |
Compare with peers
Loading peers…